Skip to main navigation
  • About
    • Overview
    • Management
    • Board
  • Science
    • Pipeline
    • Posters & Presentations
  • Patients
    • Chronic HBV Infection
    • MASH
    • Clinical Trials
    • Expanded Access Policy
  • News & Media
    • Press Releases
    • Presentations & Events
  • Investors
    • Overview
    • Stock
      • Stock Quote & Chart
      • Analyst Coverage
    • News & Events
      • Press Releases
      • Presentations & Events
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Governance Highlights
      • Committee Composition
    • Resources
      • Investor FAQs
      • Email Alerts
      • Contact Us
  • Careers
  • About
    • Overview
    • Management
    • Board
  • Science
    • Pipeline
    • Posters & Presentations
  • Patients
    • Chronic HBV Infection
    • MASH
    • Clinical Trials
    • Expanded Access Policy
  • News & Media
    • Press Releases
    • Presentations & Events
  • Investors
    • Overview
    • Stock
      • Stock Quote & Chart
      • Analyst Coverage
    • News & Events
      • Press Releases
      • Presentations & Events
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Governance Highlights
      • Committee Composition
    • Resources
      • Investor FAQs
      • Email Alerts
      • Contact Us
  • Careers
Investor Relations

Presentations & Events

Presentations

April 2026 Corporate Presentation

Upcoming Events

There are no upcoming events available at this time.

Past Events

Jul 18, 2024 3:00 PM EDT
Aligos Therapeutics Virtual KOL Event on ALG-000184: Potential First/Best-in-Class CAM-E for Chronic Hepatitis B (CHB)
View Webcast
View Presentation 4.7 MB
Mar 7, 2024 4:00 PM EST
Virtual MASH KOL Event
View Webcast
View Presentation 6.5 MB
Nov 30, 2023 12:30 PM EST
2023 Piper Sandler Healthcare Conference
View Webcast
View Presentation 6.1 MB
Nov 16, 2023 1:30 PM EST
Virtual KOL Event
View Webcast
ALG-000184 Late-Breaking Phase 1b Data from AASLD KOL Perspective on Emerging HBV Therapies 3.8 MB
Jun 8, 2023 from 8:00 AM to 8:25 AM EDT
Jefferies 2023 Healthcare Conference
View Webcast
View Presentation 2.6 MB
Jan 12, 2023 from 10:30 AM to 11:10 AM PST
41st Annual J.P. Morgan Healthcare Conference
View Webcast
View Presentation 5 MB
Jun 8, 2022 3:30 PM EDT
Jefferies Healthcare Conference
View Webcast
Jan 12, 2022 5:15 PM EST
40th Annual J.P. Morgan Healthcare Conference
View Webcast
Nov 22, 2021 10:00 AM EST
Piper Sandler 33rd Annual Virtual Healthcare Conference
View Webcast
Nov 18, 2021 8:00 AM GMT
Jefferies London Healthcare Conference
View Webcast
  • First page «
  • Previous page ‹
  • Page 1
  • Current page 2
  • Page 3
  • Next page ›
  • Last page »
Displaying 11 - 20 of 26

Print Page

Email Alerts

RSS

Investor FAQs

US OFFICE 1 Corporate Dr., 2nd Floor South San Francisco, CA 94080

EU OFFICE Gaston Geenslaan 1 / (Building 3) 3001 Leuven, Belgium +32 (0)16 88 28 10 

CHINA OFFICE Unit 3212, Building A, No. 100, Zunyi Road, Changning District, Shanghai, People’s Republic of China, 200051

Follow Us Linkedin Twitter info@aligos.com

© Aligos Therapeutics 2026

  • Privacy Policy
  • Terms of Service
Menu
  • About
    • Overview
    • Management
    • Board
  • Science
    • Pipeline
    • Posters & Presentations
  • Patients
    • Chronic HBV Infection
    • MASH
    • Clinical Trials
    • Expanded Access Policy
  • News & Media
    • Press Releases
    • Presentations & Events
  • Investors
    • Overview
    • Stock
      • Stock Quote & Chart
      • Analyst Coverage
    • News & Events
      • Press Releases
      • Presentations & Events
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Governance Highlights
      • Committee Composition
    • Resources
      • Investor FAQs
      • Email Alerts
      • Contact Us
  • Careers